Benjamine Arellano

发表

Regulatory T cell-based therapies for autoimmunity.

D. Graber, C. Sentman, Benjamine Arellano, 2016, Discovery medicine.

A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR

D. Lambracht-Washington, O. Stüve, E. Herndon, 2016, PloS one.

Human aquaporin 4281-300 is the immunodominant linear determinant in the context of HLA-DRB1*03:01: relevance for diagnosing and monitoring patients with neuromyelitis optica.

L. Steinman, J. Bennett, D. Lambracht-Washington, 2012, Archives of neurology.

Testing effects of glatiramer acetate and fingolimod in an infectious model of CNS immune surveillance

L. Hayardeny, O. Stüve, F. Yarovinsky, 2014, Journal of Neuroimmunology.

How Chimeric Antigen Receptor Design Affects Adoptive T Cell Therapy

Albert T Gacerez, C. Sentman, Benjamine Arellano, 2016, Journal of cellular physiology.

Immune surveillance of the central nervous system in multiple sclerosis — Relevance for therapy and experimental models

L. Hayardeny, O. Stüve, F. Yarovinsky, 2014, Journal of Neuroimmunology.

The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis

H. Hartung, B. Hemmer, S. Zamvil, 2013, Journal of Neuroinflammation.

Human aquaporin 4281-300 is the immunodominant linear determinant in the context of HLA-DRB1*03:01: relevance for diagnosing and monitoring patients with neuromyelitis optica.

L. Steinman, D. Lambracht-Washington, S. Zein, 2012, Archives of Neurology.

Human Aquaporin 4 281-300 Is the Immunodominant Linear Determinant in the Context of Hla-drb1*03:01 Relevance for Diagnosing and Monitoring Patients with Neuromyelitis Optica for Editorial Comment See Page 1111

D. Lambracht-Washington, S. Zein, Tresa Zacharias, 2022 .